Background: Patients with hepatitis C virus (HCV) are at increased risk for hepatocellular
carcinoma. Although serum α-fetoprotein (AFP) is often used to detect hepatocellular …

Although there is no definitive evidence that hepatocellular carcinoma (HCC) screening in
high-risk groups improves survival, many physicians screen high-risk populations with …

Abstract Background: Updated National Academy of Clinical Biochemistry Laboratory
Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

Background and aims The role of alphafetoprotein (AFP) in the diagnosis and surveillance
of hepatocellular carcinoma (HCC) is getting smaller owing to the advances in imaging …

BACKGROUND Although elevated serum alpha-fetoprotein (AFP) is often seen in patients
with chronic hepatitis C (CHC), its prevalence, risk factors, and clinical significance remain to …

Abstract Background and Objective Considered as one of the most recurrent types of liver
malignancy, Hepatocellular Carcinoma (HCC) needs to be assessed in a non-invasive way …

Current surveillance strategies for hepatocellular carcinoma (HCC) are applied uniformly in
patients with cirrhosis, regardless of their cancer risk. The aim of this study was to compare …

Abstract α-Fetoprotein (AFP) is frequently used as a diagnostic marker for hepatocellular
carcinoma (HCC). Most available data concerning AFP come from studies of patients with …

Background Hepatocellular carcinoma is the most common cause of primary liver
neoplasms and is one of the main causes of death in patients with liver cirrhosis. High Alpha …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some
areas of the world with increasing incidence worldwide. Most of patients with HCC are …